Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entresto long-term extension in pediatric heart failure
NCT03785405Phase 3Completed
- Sponsor
- Novartis
- Start
- May 2019
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 27
01
Overview
A Phase 3 trial of sacubitril + valsartan in heart failure (HF), sponsored by Novartis. Started May 2019; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03785405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03785405.